These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 16008602)
1. Clinical outcome after cyclosporine dose reduction based on C2 levels in long-term liver transplant patients. Tha-In T; Hesselink DA; Tilanus HW; Elshove L; Wilschut AL; Hansen BE; van Gelder T; Metselaar HJ Clin Transplant; 2005 Aug; 19(4):537-42. PubMed ID: 16008602 [TBL] [Abstract][Full Text] [Related]
2. Cyclosporine dose reduction in stable renal transplant patients with high C2 level: simplified method of single C2 measurement and individualization of C0 target. Higgins RM; Kanji H; Hernon M; Harrison P; Lam FT; Kashi SH Transpl Int; 2005 Jul; 18(7):806-10. PubMed ID: 15948859 [TBL] [Abstract][Full Text] [Related]
3. Impact of late conversion from C0 to C2 monitoring of microemulsified cyclosporine in pediatric living donor liver transplant recipients. Takatsuki M; Chen CL; Chen YS; Wang CC; Lin CC; Yang CH; Yong CC; Liu YW Clin Transplant; 2004 Dec; 18(6):694-9. PubMed ID: 15516246 [TBL] [Abstract][Full Text] [Related]
4. A randomized, controlled trial of C0- Vs C2-guided therapeutic drug monitoring of cyclosporine in stable heart transplant patients. Mathias HC; Ozalp F; Will MB; Borland W; Payne C; Kerr M; Lockhart J; Murday AJ J Heart Lung Transplant; 2005 Dec; 24(12):2137-43. PubMed ID: 16364862 [TBL] [Abstract][Full Text] [Related]
6. Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients. Cole E; Maham N; Cardella C; Cattran D; Fenton S; Hamel J; O'Grady C; Smith R Transplantation; 2003 Jun; 75(12):2086-90. PubMed ID: 12829917 [TBL] [Abstract][Full Text] [Related]
7. Monitoring of cyclosporine 2-hour post-dose levels in heart transplantation: improvement in clinical outcomes. Delgado DH; Rao V; Hamel J; Miriuka S; Cusimano RJ; Ross HJ J Heart Lung Transplant; 2005 Sep; 24(9):1343-6. PubMed ID: 16143255 [TBL] [Abstract][Full Text] [Related]
8. Switching monitoring of emulsified cyclosporine from trough level to 2-hour level in stable liver transplant patients. Langers P; Cremers SC; den Hartigh J; Veenendaal RA; ten Hove WR; Ringers J; Lamers CB; van Hoek B Liver Transpl; 2004 Feb; 10(2):183-9. PubMed ID: 14762854 [TBL] [Abstract][Full Text] [Related]
9. C2 monitoring of cyclosporine in stable renal transplant patients results in lower costs and improved renal function. Domínguez J; Fuenzalida D; Norambuena R; Pais E; Cortes Monroy G; Llanos R Transplant Proc; 2005 Apr; 37(3):1583-5. PubMed ID: 15866680 [TBL] [Abstract][Full Text] [Related]
10. Experience with cyclosporine: approaching the therapeutic window for C2 levels in maintenance kidney transplant recipients. Di Paolo S; Teutonico A; Infante B; Stallone G; Schena A; Grandaliano G; Battaglia M; Di Tonno P; Schena FP Transplant Proc; 2004 Mar; 36(2 Suppl):434S-436S. PubMed ID: 15041381 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of cyclosporine C2 levels in long-term stable renal allograft recipients. Hu RH; Tsai MK; Lee PH Transplant Proc; 2004 Sep; 36(7):2105-7. PubMed ID: 15518762 [TBL] [Abstract][Full Text] [Related]
12. Association between cyclosporine concentrations at 2 hours post-dose and clinical outcomes in de novo lung transplant recipients. Akhlaghi F; Gonzalez L; Trull AK J Heart Lung Transplant; 2005 Dec; 24(12):2120-8. PubMed ID: 16364860 [TBL] [Abstract][Full Text] [Related]
14. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose. Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449 [TBL] [Abstract][Full Text] [Related]
15. Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression. Kandaswamy R; Humar A; Casingal V; Gillingham KJ; Ibrahim H; Matas AJ Transplantation; 2007 Mar; 83(6):722-6. PubMed ID: 17414704 [TBL] [Abstract][Full Text] [Related]
16. Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases. Büchler M; Chadban S; Cole E; Midtvedt K; Thervet E; Prestele H; Keown P Nephrol Dial Transplant; 2006 Jan; 21(1):197-202. PubMed ID: 16204301 [TBL] [Abstract][Full Text] [Related]
17. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral. Al Wakeel JS; Shaheen FA; Mathew MC; Abou Zeinab HM; Al Alfi A; Tarif NM; Al Mousawi MS; Mahmoud TS; Alorrayed AS; Fagir EA; Dham RS; Shaker DS Transplant Proc; 2008 Sep; 40(7):2245-51. PubMed ID: 18790205 [TBL] [Abstract][Full Text] [Related]
18. Target range maximum of cyclosporine blood concentration two hours post dose in stable liver transplant patients. Li J; Dahmen U; Beckebaum S; Cicinnati V; Valentin-Gamazo C; Frilling A; Malago M; Broelsch CE Eur J Med Res; 2006 Apr; 11(4):139-45. PubMed ID: 16720277 [TBL] [Abstract][Full Text] [Related]
19. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients. Paydaş S; Balal M; Sertdemir Y; Seyrek N; Karayaylali I Ren Fail; 2005; 27(4):409-13. PubMed ID: 16060128 [TBL] [Abstract][Full Text] [Related]